MA39374A1 - Triterpénoïdes présentant une activité d'inhibition de la maturation du vih, substitués en 3ème position par un cycle non aromatique portant un substituant halogénoalkyle - Google Patents
Triterpénoïdes présentant une activité d'inhibition de la maturation du vih, substitués en 3ème position par un cycle non aromatique portant un substituant halogénoalkyleInfo
- Publication number
- MA39374A1 MA39374A1 MA39374A MA39374A MA39374A1 MA 39374 A1 MA39374 A1 MA 39374A1 MA 39374 A MA39374 A MA 39374A MA 39374 A MA39374 A MA 39374A MA 39374 A1 MA39374 A1 MA 39374A1
- Authority
- MA
- Morocco
- Prior art keywords
- triterpenoids
- substituted
- aromatic ring
- inhibition activity
- ring bearing
- Prior art date
Links
- 150000003648 triterpenes Chemical class 0.000 title abstract 2
- 230000000694 effects Effects 0.000 title 1
- 230000001747 exhibiting effect Effects 0.000 title 1
- 230000005764 inhibitory process Effects 0.000 title 1
- 230000035800 maturation Effects 0.000 title 1
- 125000006574 non-aromatic ring group Chemical group 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 230000000975 bioactive effect Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
- C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
- C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
- C07C309/66—Methanesulfonates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
- C07D239/12—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/12—1,4-Thiazines; Hydrogenated 1,4-thiazines not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/04—Esters of boric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La présente invention concerne des composés dotés de propriétés pharmaceutiques et bioactives, leurs compositions pharmaceutiques et des procédés d'utilisation. En particulier, des triterpénoïdes qui présentent une activité antivirale unique sont utilisés comme inhibiteurs de maturation du vih, tels que représentés par des composés de formule i : avec x choisi parmi un cycle c
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461978306P | 2014-04-11 | 2014-04-11 | |
| PCT/US2015/025029 WO2015157483A1 (fr) | 2014-04-11 | 2015-04-09 | Triterpénoïdes présentant une activité d'inhibition de la maturation du vih, substitués en 3ème position par un cycle non aromatique portant un substituant halogénoalkyle |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA39374A1 true MA39374A1 (fr) | 2018-06-29 |
Family
ID=53002809
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA39374A MA39374A1 (fr) | 2014-04-11 | 2015-04-09 | Triterpénoïdes présentant une activité d'inhibition de la maturation du vih, substitués en 3ème position par un cycle non aromatique portant un substituant halogénoalkyle |
Country Status (36)
| Country | Link |
|---|---|
| US (5) | US9527882B2 (fr) |
| EP (2) | EP3129392B1 (fr) |
| JP (1) | JP6568202B2 (fr) |
| KR (1) | KR102411082B1 (fr) |
| CN (1) | CN106604909B (fr) |
| AR (1) | AR101077A1 (fr) |
| AU (1) | AU2015243500B2 (fr) |
| BR (1) | BR112016023414B1 (fr) |
| CA (1) | CA2944778C (fr) |
| CL (1) | CL2016002528A1 (fr) |
| CR (1) | CR20160472A (fr) |
| CY (1) | CY1123742T1 (fr) |
| DK (1) | DK3129392T3 (fr) |
| DO (1) | DOP2016000277A (fr) |
| EA (1) | EA030178B1 (fr) |
| ES (1) | ES2828705T3 (fr) |
| HR (1) | HRP20201645T1 (fr) |
| HU (1) | HUE051719T2 (fr) |
| IL (1) | IL248053B (fr) |
| LT (1) | LT3129392T (fr) |
| MA (1) | MA39374A1 (fr) |
| MX (1) | MX2016013425A (fr) |
| NZ (1) | NZ724644A (fr) |
| PE (1) | PE20161391A1 (fr) |
| PH (1) | PH12016501951B1 (fr) |
| PL (1) | PL3129392T3 (fr) |
| PT (1) | PT3129392T (fr) |
| RS (1) | RS60959B1 (fr) |
| SG (2) | SG11201608041QA (fr) |
| SI (1) | SI3129392T1 (fr) |
| SM (1) | SMT202000581T1 (fr) |
| TW (1) | TWI659964B (fr) |
| UA (1) | UA120927C2 (fr) |
| UY (1) | UY36070A (fr) |
| WO (1) | WO2015157483A1 (fr) |
| ZA (1) | ZA201606748B (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY36070A (es) | 2014-04-11 | 2015-10-30 | Bristol Myers Squibb Company Una Corporación Del Estado De Delaware | Triterpenoides con actividad inhibidora de la maduración de hiv |
| RU2018116772A (ru) * | 2015-11-20 | 2019-12-20 | ВАЙВ ХЕЛТКЕР ЮКей (N4) ЛИМИТЕД | Композиции ингибитора созревания ВИЧ |
| AR107512A1 (es) * | 2016-02-04 | 2018-05-09 | VIIV HEALTHCARE UK Nº 5 LTD | Triterpenoides modificados en c-3 y c-17 como inhibidores del vih-1 |
| JP2019528304A (ja) * | 2016-08-31 | 2019-10-10 | ヴィーブ ヘルスケア カンパニー | 組み合わせ並びにその使用及び治療 |
| PT3784349T (pt) * | 2018-04-24 | 2024-01-22 | Viiv Healthcare Uk No 5 Ltd | Compostos com atividade inibidora de maturação do hiv |
| SI3894424T1 (sl) | 2018-12-10 | 2023-04-28 | Viiv Healthcare Uk (No. 4) Limited | Mezilatna sol amino-lupanske spojine z zaviralno aktivnostjo dozorevanja HIV-a |
| CN109705189B (zh) * | 2018-12-29 | 2020-06-05 | 中国医学科学院药用植物研究所 | 具有式i所示结构的三萜衍生物及其制备方法和应用 |
| CN110981765A (zh) * | 2019-11-07 | 2020-04-10 | 肇庆巨元生化有限公司 | 一种25-羟基维生素d3中间体的制备方法 |
| US20230045509A1 (en) * | 2019-12-09 | 2023-02-09 | Viiv Healthcare Company | Pharmaceutical compositions comprising cabotegravir |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4906661A (en) | 1981-11-12 | 1990-03-06 | E. I. Du Pont De Nemours And Company | Esters of aryloxypropanolamine derivatives |
| US5413999A (en) | 1991-11-08 | 1995-05-09 | Merck & Co., Inc. | HIV protease inhibitors useful for the treatment of AIDS |
| US5679828A (en) | 1995-06-05 | 1997-10-21 | Biotech Research Labs, Inc. | Betulinic acid and dihydrobetulinic acid derivatives and uses therefor |
| AR035311A1 (es) | 1999-01-27 | 2004-05-12 | Wyeth Corp | Derivados de acido hidroxamico que contienen alquinilo, como inhibidores de las metalloproteinasas de matriz y de la tace, composicion farmaceutica y el uso de los mismos para la manufactura de un medicamento |
| US20040110785A1 (en) | 2001-02-02 | 2004-06-10 | Tao Wang | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| US7365221B2 (en) | 2002-09-26 | 2008-04-29 | Panacos Pharmaceuticals, Inc. | Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof |
| US7745625B2 (en) | 2004-03-15 | 2010-06-29 | Bristol-Myers Squibb Company | Prodrugs of piperazine and substituted piperidine antiviral agents |
| CA2560266A1 (fr) | 2004-03-17 | 2005-09-29 | Panacos Pharmaceuticals, Inc. | Sels pharmaceutiques de l'acide 3-<i>o</i>-(3',3'-dimethylsuccinyl)betulinique |
| TW200628161A (en) | 2004-11-12 | 2006-08-16 | Panacos Pharmaceuticals Inc | Novel betulin derivatives, preparation thereof and use thereof |
| US20090105203A1 (en) | 2006-10-16 | 2009-04-23 | Myriad Genetics, Incorporated | Compounds for treating viral infections |
| US20090062243A1 (en) * | 2007-08-03 | 2009-03-05 | Advanced Life Sciences, Inc. | Lupane-Type Triterpenoids Modified at 30-Position and Analogues Thereof |
| CA2714049A1 (fr) | 2008-02-14 | 2009-08-20 | Virochem Pharma Inc. | Nouveaux derives de 17ss-lupane |
| US9067966B2 (en) | 2009-07-14 | 2015-06-30 | Hetero Research Foundation, Hetero Drugs Ltd. | Lupeol-type triterpene derivatives as antivirals |
| WO2011153315A1 (fr) * | 2010-06-04 | 2011-12-08 | Bristol-Myers Squibb Company | Dérivés d'acide bétulinique modifiés en c-3, utilisés comme inhibiteurs de maturation du vih |
| PT2576586E (pt) | 2010-06-04 | 2015-10-23 | Bristol Myers Squibb Co | Amidas c-28 de derivados de ácido betulínico c-3 modificadas como inibidores de maturação de hiv |
| SG192144A1 (en) | 2011-01-31 | 2013-08-30 | Bristol Myers Squibb Co | C-17 and c-3 modified triterpenoids with hiv maturation inhibitory activity |
| ES2552512T3 (es) | 2011-01-31 | 2015-11-30 | Bristol-Myers Squibb Company | Aminas C-28 de derivados de ácido betulínico modificado en C-3 como inhibidores de la maduracion del virus de inmunodeficiencia humana |
| US8906889B2 (en) | 2012-02-15 | 2014-12-09 | Bristol-Myers Squibb Company | C-3 cycloalkenyl triterpenoids with HIV maturation inhibitory activity |
| US8889854B2 (en) * | 2012-05-07 | 2014-11-18 | Bristol-Myers Squibb Company | C-17 bicyclic amines of triterpenoids with HIV maturation inhibitory activity |
| UY36070A (es) | 2014-04-11 | 2015-10-30 | Bristol Myers Squibb Company Una Corporación Del Estado De Delaware | Triterpenoides con actividad inhibidora de la maduración de hiv |
-
2015
- 2015-04-09 UY UY0001036070A patent/UY36070A/es not_active Application Discontinuation
- 2015-04-09 PE PE2016001948A patent/PE20161391A1/es unknown
- 2015-04-09 EA EA201691760A patent/EA030178B1/ru unknown
- 2015-04-09 PT PT157184029T patent/PT3129392T/pt unknown
- 2015-04-09 BR BR112016023414-6A patent/BR112016023414B1/pt active IP Right Grant
- 2015-04-09 HU HUE15718402A patent/HUE051719T2/hu unknown
- 2015-04-09 UA UAA201609970A patent/UA120927C2/uk unknown
- 2015-04-09 JP JP2017504607A patent/JP6568202B2/ja active Active
- 2015-04-09 EP EP15718402.9A patent/EP3129392B1/fr active Active
- 2015-04-09 LT LTEP15718402.9T patent/LT3129392T/lt unknown
- 2015-04-09 SI SI201531396T patent/SI3129392T1/sl unknown
- 2015-04-09 CN CN201580031487.2A patent/CN106604909B/zh active Active
- 2015-04-09 DK DK15718402.9T patent/DK3129392T3/da active
- 2015-04-09 NZ NZ724644A patent/NZ724644A/en unknown
- 2015-04-09 CA CA2944778A patent/CA2944778C/fr active Active
- 2015-04-09 US US14/682,179 patent/US9527882B2/en active Active
- 2015-04-09 SM SM20200581T patent/SMT202000581T1/it unknown
- 2015-04-09 MX MX2016013425A patent/MX2016013425A/es active IP Right Grant
- 2015-04-09 CR CR20160472A patent/CR20160472A/es unknown
- 2015-04-09 RS RS20201276A patent/RS60959B1/sr unknown
- 2015-04-09 EP EP20187878.2A patent/EP3750910A1/fr not_active Withdrawn
- 2015-04-09 TW TW104111466A patent/TWI659964B/zh active
- 2015-04-09 PL PL15718402T patent/PL3129392T3/pl unknown
- 2015-04-09 AR ARP150101078A patent/AR101077A1/es unknown
- 2015-04-09 SG SG11201608041QA patent/SG11201608041QA/en unknown
- 2015-04-09 AU AU2015243500A patent/AU2015243500B2/en active Active
- 2015-04-09 WO PCT/US2015/025029 patent/WO2015157483A1/fr active Application Filing
- 2015-04-09 KR KR1020167031312A patent/KR102411082B1/ko active IP Right Grant
- 2015-04-09 SG SG10201709017PA patent/SG10201709017PA/en unknown
- 2015-04-09 ES ES15718402T patent/ES2828705T3/es active Active
- 2015-04-09 MA MA39374A patent/MA39374A1/fr unknown
-
2016
- 2016-09-26 IL IL248053A patent/IL248053B/en active IP Right Grant
- 2016-09-29 ZA ZA2016/06748A patent/ZA201606748B/en unknown
- 2016-10-03 PH PH12016501951A patent/PH12016501951B1/en unknown
- 2016-10-05 CL CL2016002528A patent/CL2016002528A1/es unknown
- 2016-10-11 DO DO2016000277A patent/DOP2016000277A/es unknown
- 2016-11-07 US US15/344,756 patent/US20170056420A1/en not_active Abandoned
-
2017
- 2017-08-16 US US15/678,381 patent/US10245275B2/en active Active
-
2019
- 2019-01-22 US US16/253,393 patent/US10780102B2/en active Active
-
2020
- 2020-08-03 US US16/983,052 patent/US11464790B2/en active Active
- 2020-10-13 HR HRP20201645TT patent/HRP20201645T1/hr unknown
- 2020-10-27 CY CY20201101017T patent/CY1123742T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA39374A1 (fr) | Triterpénoïdes présentant une activité d'inhibition de la maturation du vih, substitués en 3ème position par un cycle non aromatique portant un substituant halogénoalkyle | |
| MA41562B1 (fr) | Agonistes d'apj 4-hydroxy-3-(heteroaryl)pyridine-2-one a utiliser dans le traitement de troubles cardio-vasculaires | |
| MX2019009861A (es) | Composiciones farmaceuticas de un derivado de acido biliar y microbioma y usos de las mismas. | |
| MD3464249T2 (ro) | Derivați carbonucleozidici substituiţi utili în calitate de agenți anticanceroşi | |
| MA39317A1 (fr) | Dérivés de nucléosides à substitution 4'-difluorométhyle utilisés en tant qu'inhibiteurs de la réplication de l'arn du virus de la grippe | |
| PH12020550786A1 (en) | Novel benzylamino substituted pyridopyrimidinones and derivatives as sos1 inhibitors | |
| MA42109B1 (fr) | Amides hétérocycliques utilisés en tant qu'inhibiteurs de kinase | |
| MA34909B1 (fr) | Triterpénoïdes modifi2s en c-17 et c-3 presentant une activité inhibitrice de la maturation du vih | |
| MA37959A2 (fr) | Dérivés de 5-phénoxy-3h-pyrimidin-4-one et leur utilisation en tant qu'inhibiteurs de la transcriptase inverse du vih | |
| BR112018003026A2 (pt) | composições compreendendo um inibidor de pi3k e um inibidor de hdac | |
| MA39193A1 (fr) | Modulateurs du gpr6 à base de tétrahydropyridopyrazines | |
| EA201691794A1 (ru) | Конденсированные [1,4]диазепиновые соединения в качестве ингибиторов продукции аутотаксина (atx) и лизофосфатидиловой кислоты (lpa) | |
| MA40225A (fr) | Composés dihydroisoquinolinone substitués | |
| GEP20196949B (en) | 2-amino-6-(difluoromethyl)-5, 5-difluoro-6-phenyl-3, 4, 5, 6-tetra- hydropyridines as bace1 inhibitors | |
| MA39152A1 (fr) | Cyclopentanes substitués en 1,2 utilisés comme antagonistes du récepteur d'orexine | |
| MX2018013164A (es) | Compuestos novedosos de imidazopiridina sustituida como inhibidores de indolamina-2,3-dioxigenasa y/o triptofano-2,3-dioxigenasa. | |
| UY37764A (es) | Nuevos compuestos inhibidores de la prostaglandina d sintasa hematopoyética (h-pgds) | |
| MY195881A (en) | Griseofulvin Compound | |
| NZ746906A (en) | Oxaborole esters and uses thereof | |
| PH12014502285A1 (en) | Anti-malarial agents | |
| MA40366A (fr) | Dérivés de tétrahydroquinoline à titre d'inhibiteurs des bromodomaines | |
| MA38678A1 (fr) | Dérivés nucléosidiques 4'-azido, 3'désoxy-3'-fluoro substitués | |
| MA40110B2 (fr) | Dérivés de 7-(morpholinyl)-2-(n-pipérazinyl)méthylthiéno[2, 3-c]pyridine en tant que médicaments anticancéreux | |
| MA43960B1 (fr) | Triterpénoïdes modifiés en c-3 et c-17 utilisés comme inhibiteurs du vih-1 | |
| MA39253A1 (fr) | Composés hétéroaryle bicycliques substitués utilisés comme agonistes de rxr |